E. V. Loftus, Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences, Gastroenterology, vol.126, pp.1504-1517, 2004.

P. Seksik, Review article: The role of bacteria in onset and perpetuation of inflammatory bowel disease, Aliment Pharmacol Ther, vol.24, pp.11-18, 2006.
URL : https://hal.archives-ouvertes.fr/hal-02668973

P. Rutgeerts, Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum, Lancet, vol.338, pp.771-774, 1991.

A. Darfeuille-michaud, Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease, Gastroenterology, vol.115, pp.1405-1413, 1998.

H. Sokol, P. Lepage, P. Seksik, J. Dore, and P. Marteau, Molecular comparison of dominant microbiota associated with injured versus healthy mucosa in ulcerative colitis, Gut, vol.56, pp.152-154, 2007.

H. Sokol, Specificities of the fecal microbiota in inflammatory bowel disease, Inflamm Bowel Dis, vol.12, pp.106-111, 2006.
URL : https://hal.archives-ouvertes.fr/hal-02663416

A. Swidsinski, J. Weber, V. Loening-baucke, L. P. Hale, and H. Lochs, Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease, J Clin Microbiol, vol.43, pp.3380-3389, 2005.

C. Manichanh, Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach, Gut, vol.55, pp.205-211, 2006.

D. N. Frank, Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases, Proc Natl Acad Sci, vol.104, pp.13780-13785, 2007.

M. Martinez-medina, X. Aldeguer, F. Gonzalez-huix, D. Acero, and G. Lj, Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophoresis, Inflamm Bowel Dis, vol.12, pp.1136-1145, 2006.

P. Marteau, Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: A randomised, double blind, placebo controlled GETAID trial, Gut, vol.55, pp.842-847, 2006.

C. Daniel, Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model, Appl Environ Microbiol, vol.72, pp.5799-5805, 2006.

J. P. Segain, Butyrate inhibits inflammatory responses through NFkappaB inhibition: Implications for Crohn's disease, Gut, vol.47, pp.397-403, 2000.

A. Mayr-harting, A. J. Hedges, and R. Berkeley, Methods for studying bacteriocins, Methods Microbiol, vol.7, pp.315-422, 1972.

J. Dabard, Ruminococcin A, a new lantibiotic produced by a Ruminococcus gnavus strain isolated from human feces, Appl Environ Microbiol, vol.67, pp.4111-4118, 2001.
URL : https://hal.archives-ouvertes.fr/hal-02677754

S. Rakoff-nahoum, J. Paglino, F. Eslami-varzaneh, S. Edberg, and R. Medzhitov, Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis, Cell, vol.118, pp.229-241, 2004.

D. Kelly, Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA, Nat Immunol, vol.5, pp.104-112, 2004.

A. Barcenilla, Phylogenetic relationships of butyrate-producing bacteria from the human gut, Appl Environ Microbiol, vol.66, pp.1654-1661, 2000.

A. Suau, Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut, Appl Environ Microbiol, vol.65, pp.4799-4807, 1999.

J. Wehkamp, NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression, Gut, vol.53, pp.1658-1664, 2004.

J. Wehkamp, Reduced Paneth cell alpha-defensins in ileal Crohn's disease, Proc Natl Acad Sci, vol.102, pp.18129-18134, 2005.

J. Wehkamp, NF-kappaB-and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: A novel effect of a probiotic bacterium, Infect Immun, vol.72, pp.5750-5758, 2004.

A. Nenci, Epithelial NEMO links innate immunity to chronic intestinal inflammation, Nature, vol.446, pp.557-561, 2007.

B. Foligné, C. Grangette, and B. Pot, Probiotics in IBD: Mucosal and systemic routes of administration may promote similar effects, Gut, vol.54, pp.727-728, 2005.

D. Rachmilewitz, Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis, Gastroenterology, vol.126, pp.520-528, 2004.

B. Sheil, Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis, Gut, vol.53, pp.694-700, 2004.

N. Vasquez, Patchy distribution of mucosal lesions in ileal Crohn's disease is not linked to differences in the dominant mucosa-associated bacteria: A study using fluorescence in situ hybridization and temporal temperature gradient gel electrophoresis, Inflamm Bowel Dis, vol.13, pp.684-692, 2007.

A. Lan, Survival and metabolic activity of selected strains of Propionibacterium freudenreichii in the gastrointestinal tract of human microbiota-associated rats, Br J Nutr, vol.97, pp.714-724, 2007.
URL : https://hal.archives-ouvertes.fr/hal-02669108

B. Foligne, Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria, World J Gastroenterol, vol.13, pp.236-243, 2007.

B. Foligne, Recommendations for improved use of the murine TNBS-induced colitis model in evaluating anti-inflammatory properties of lactic acid bacteria: technical and microbiological aspects, Dig Dis Sci, vol.51, pp.390-400, 2006.

J. L. Wallace, W. K. Macnaughton, G. P. Morris, and P. L. Beck, Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease, Gastroenterology, vol.96, pp.29-36, 1989.

C. K. Ameho, Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor alpha production in trinitrobenzene sulphonic acid induced colitis, Gut, vol.41, pp.487-493, 1997.